Literature DB >> 21912254

Molecular genetics of the blood group I system and the regulation of I antigen expression during erythropoiesis and granulopoiesis.

Lung-Chih Yu1, Marie Lin.   

Abstract

PURPOSE OF REVIEW: The molecular genetics of the blood group I system and the regulation mechanism for I antigen expression in postnatal red blood cells are intriguing. This review summarizes their elucidation and recent findings. RECENT
FINDINGS: Accumulating data from the molecular analysis of individuals with the adult i phenotype supports the proposed molecular genetic mechanism for the partial association of the adult i phenotype with congenital cataracts. Recent investigations have shown that the regulation of I antigen formation during erythropoiesis is determined by transcription factor CCAAT/enhancer binding protein-α (C/EBPα) and the phosphorylation status of C/EBPα Ser-21 residue.
SUMMARY: The human I locus is organized such that it has an uncommon genetic architecture and expresses three different I transcript forms. The results obtained from molecular analysis of two adult i groups, with and without congenital cataracts, demonstrate that the molecular background accounts for the partial association between these two traits and suggest that an I gene defect may lead directly to the development of congenital cataracts. Analysis of the regulation for I antigen expression shows that the regulation during erythropoiesis and granulopoiesis share a common mechanism, with dephosphorylation of the Ser-21 residue on C/EBPα playing the critical role.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912254     DOI: 10.1097/MOH.0b013e32834baae9

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  4 in total

1.  Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment.

Authors:  Christiane E Kupper; Ruben R Rosencrantz; Birgit Henßen; Helena Pelantová; Stephan Thönes; Anna Drozdová; Vladimir Křen; Lothar Elling
Journal:  Beilstein J Org Chem       Date:  2012-05-09       Impact factor: 2.883

Review 2.  Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.

Authors:  M Perez; A Chakraborty; L S Lau; N B B Mohammed; C J Dimitroff
Journal:  Br J Dermatol       Date:  2021-05-04       Impact factor: 11.113

3.  Deletion at the GCNT2 Locus Causes Autosomal Recessive Congenital Cataracts.

Authors:  Bushra Irum; Shahid Y Khan; Muhammad Ali; Muhammad Daud; Firoz Kabir; Bushra Rauf; Fareeha Fatima; Hira Iqbal; Arif O Khan; Saif Al Obaisi; Muhammad Asif Naeem; Idrees A Nasir; Shaheen N Khan; Tayyab Husnain; Sheikh Riazuddin; Javed Akram; Allen O Eghrari; S Amer Riazuddin
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 4.  Histo-blood group glycans in the context of personalized medicine.

Authors:  Viktoria Dotz; Manfred Wuhrer
Journal:  Biochim Biophys Acta       Date:  2015-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.